These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17650293)

  • 1. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
    Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
    J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.
    Hahné S; Ramsay M; Balogun K; Edmunds WJ; Mortimer P
    J Clin Virol; 2004 Apr; 29(4):211-20. PubMed ID: 15018847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status.
    Day CA; White B; Dore GJ; van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L
    Drug Alcohol Depend; 2010 Apr; 108(1-2):134-7. PubMed ID: 20047803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus serum profiles in injection drug users and rates of immunization over time in Barcelona: 1987-2006.
    Rivas I; Martinez E; Sanvisens A; Bolao F; Tor J; Torrens M; Pujol R; Fuster D; Rey-Joly C; Muñoz A; Muga R
    Drug Alcohol Depend; 2010 Aug; 110(3):234-9. PubMed ID: 20456873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ
    Vaccine; 2006 Mar; 24(13):2377-86. PubMed ID: 16384627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
    Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
    Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users.
    Mössner BK; Skamling M; Jørgensen TR; Georgsen J; Pedersen C; Christensen PB
    J Med Virol; 2010 Oct; 82(10):1635-9. PubMed ID: 20827758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
    Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D
    J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements?
    Hope VD; Ncube F; Hickman M; Judd A; Parry JV
    J Viral Hepat; 2007 Sep; 14(9):653-60. PubMed ID: 17697018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with exposure to hepatitis B virus in injection drug users.
    Backmund M; Meyer K; Schuetz C; Reimer J
    Drug Alcohol Depend; 2006 Sep; 84(2):154-9. PubMed ID: 16481128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users.
    Ferreira RC; Rodrigues FP; Teles SA; Lopes CL; Motta-Castro AR; Novais AC; Souto FJ; Martins RM
    J Med Virol; 2009 Apr; 81(4):602-9. PubMed ID: 19235862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons.
    Hutchinson SJ; Wadd S; Taylor A; Bird SM; Mitchell A; Morrison DS; Ahmed S; Goldberg DJ
    Vaccine; 2004 Nov; 23(2):210-4. PubMed ID: 15531039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent.
    Trinks J; Cuestas ML; Tanaka Y; Mathet VL; Minassian ML; Rivero CW; Benetucci JA; Gímenez ED; Segura M; Bobillo MC; Corach D; Ghiringhelli PD; Sánchez DO; Avila MM; Peralta LA; Kurbanov F; Weissenbacher MC; Simmonds P; Mizokami M; Oubiña JR
    J Viral Hepat; 2008 Nov; 15(11):827-38. PubMed ID: 18507755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville.
    Vallejo F; Toro C; de la Fuente L; Brugal MT; Soriano V; Silva TC; Bravo MJ; Ballesta R; Barrio G;
    Eur Addict Res; 2008; 14(3):116-24. PubMed ID: 18552487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
    Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
    Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.